S.Biomedics Co., Ltd. Report issue

For profit Phase 2
Founded: Antwerp Belgium (2017)

Organization Overview

First Clinical Trial
2020
NCT04818203
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

S.Biomedics Co., Ltd.